Dokkyo Medical Journal
Online ISSN : 2436-522X
Print ISSN : 2436-5211

This article has now been updated. Please use the final version.

Comparison of the Therapeutic Effects on the Renal and Life Prognosis in ANCA-associated Nephritis
Shohei YokoyamaAkihiro Tojo
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 2023-006


ANCA-associated rapidly progressive glomerulonephritis has been treated with steroid pulse therapy (mPSL pulse), cyclophosphamide pulse therapy (IVCY), rituximab (RTX), and plasma exchange (PE), but the differences in renal and life outcomes are not fully understood. To determine the long-term prognostic impact of plasma exchange in ANCA-associated rapidly progressive glomerulonephritis, we conducted a retrospective observational study with stratification by treatment modality to determine the prognostic impact of plasma exchange in ANCA-associated rapidly progressive glomerulonephritis. Eighty patients with ANCA-associated glomerulonephritis who underwent renal biopsy at our hospital were divided into 5 groups, and the renal and life prognosis were evaluated. IVCY and RTX significantly improved renal survival compared with steroid therapy and PE. PE and PSL oral groups did not improve renal prognosis, but survived without death during the observation period. PE is introduced in patients requiring hemodialysis at biopsy to rapidly reduce ANCA levels with favorable life prognosis.

Content from these authors
© 2023 Dokkyo Medical Society

This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (